Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Re (RMAX) EBITDA (2016 - 2025)

Historic EBITDA for Re (RMAX) over the last 14 years, with Q3 2025 value amounting to $18.9 million.

  • Re's EBITDA rose 1961.93% to $18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.4 million, marking a year-over-year increase of 5850.05%. This contributed to the annual value of $42.6 million for FY2024, which is 62330.1% up from last year.
  • Re's EBITDA amounted to $18.9 million in Q3 2025, which was up 1961.93% from $14.6 million recorded in Q2 2025.
  • Over the past 5 years, Re's EBITDA peaked at $18.9 million during Q3 2025, and registered a low of -$37.6 million during Q3 2021.
  • For the 5-year period, Re's EBITDA averaged around $5.2 million, with its median value being $7.6 million (2022).
  • In the last 5 years, Re's EBITDA crashed by 50110.79% in 2023 and then surged by 17529.76% in 2024.
  • Re's EBITDA (Quarter) stood at $10.4 million in 2021, then dropped by 18.88% to $8.5 million in 2022, then plummeted by 214.58% to -$9.7 million in 2023, then skyrocketed by 150.22% to $4.9 million in 2024, then skyrocketed by 288.28% to $18.9 million in 2025.
  • Its EBITDA was $18.9 million in Q3 2025, compared to $14.6 million in Q2 2025 and $6.0 million in Q1 2025.